http://www.blueshiftbiotech.com
Blueshift Biotechnologies, Inc. is a privately funded technology company headquartered in the San Francisco Bay Area. Blueshift is adapting semiconductor inspection technology to develop powerful new screening platforms for life sciences research. The platforms are based on Dynamic Fluorimetry which denotes measurements beyond intensity and color: specifically anisotropy and lifetime. Measurements made from these methods provide information on the local environment and binding state of molecules. Our instruments provide information and speed previously unavailable to pharmaceutical research. The company has assembled an experienced management and technical team with a diverse background from the semiconductor, data storage, and biotechnology industries. Blueshift Biotechnologies is pursuing collaborations to enable technology and efficiently commercialize products for drug discovery.
Triosyn Corp. has developed a unique antimicrobial technology for use in products designed to fight against microbial threats. In extensive third-party laboratory testing, the company's core technology, Triosyn® resin, is proven effective against a broad spectrum of microorganisms. Triosyn® resin is versatile and equally effective in fluid, air, surface and dermatological applications. The company has developed a diversified portfolio of products in several areas, including air filtration (such as facemasks), paints and coatings, dermatological treatments, barrier textiles, protective clothing, and the purification of fluids.
CombiMatrix Corporation, formerly Acacia Research-CombiMatrix, is a biotechnology company, with a subsidiary, CombiMatrix Molecular Diagnostics, Inc. (CMDX). CombiMatrix's electrochemical manufacturing process utilizes standard semiconductor technology, software and chemistry to build arrays of materials. The Company's CustomArray products are deoxyribonucleic acid (DNA) microarrays, which have uses in pharmaceutical, biotech and agrochemical industries, as well as in research and government markets. The Company also uses its technology in synergistic internal programs for diagnostics development, drug development, and biodefense in addition to partnerships for nanomaterials development.
Biotage AB, formerly Pyrosequencing AB, is a Sweden-based company active within the biotechnology sector. The Company provides solutions in the areas of medicinal and analytical chemistry, process development and genetic analysis. Its business activities are divided into two segments: Discovery Chemistry and Biosystems. The Discovery Chemistry area supplies systems and consumables within pharmaceutical chemistry, including such areas as synthesis, work-up, purification and evaporation. Its solutions are marketed under the brand names of Initiator, Advancer, ISOLUTE, EVOLUTE, Isolera, FlashMaster and others. The Biosystems area offers systems for genetic analysis, mainly for the use in clinical research. It focuses its operations on two application areas: infectious disease and cancer research. The Biosystems’ activities are based on the Pyrosequencing technology, in which a sample’s deoxyribonucleic acid (DNA) sequences are read in real time with the help of sequencing by synthesis.
Privacy Policy | Terms and Conditions | Do Not Sell My Personal Information | Websites Directory
Copyright © 2022 kwtbox.com. All Rights Reserved. US Business Directory